Related to Translational Medicine Center for Infectious Diseases Set Up in Shanghai

• S-Evans Biosciences Gains Chinese Rights to Cryo-Cell’s Menstrual Stem Cell Technology
  
• Forest Licenses Antibiotic to AstraZeneca in Europe and Other Markets
  
• FDA Raps J&J's Knuckles over Clinical Trials of Ceftobiprole Antibiotic
  
• Regulation of Antimicrobial Peptide by Vitamin D Found to Have Been Conserved for 60M Years
  
• Sinovac to Supply Flu Vaccine to Beijing Citizens
  
• HUYA Negotiates Exclusive Early Access to Drug Candidates Developed at Chinese Academy of Sciences
  
• BioTime Sets Up Subsidiary in China to Develop Stem Cell Therapeutics
  
• Prodrug of Eisai’s Antifungal to Be Investigated in Chagas
  
• AVI BioPharma Obtains Expanded DoD Contract Worth $11.5M for Its Junin Virus Infection Treatment
  
• GSK Furthers Interest in China through Pediatric Vaccines JV with Initial $32M Investment
  
• Gen-Probe to Pay $60M in Prodesse Buyout
  
• Daiichi Sankyo and MorphoSys Collaborate on Antibody Therapeutics Against Nosocomial Infections
  
• ZyGEM and Phthisis Diagnostics to Develop Tools to Detect Infectious Pathogens
  
• BD to Acquire HandyLab for Molecular Diagnostic Automation Platform
  
• Protein Discovered that Silences Genes by Coordinating Heterochromatin Assembly
  
• FDA Approves AdvanDx’ Faster PNA FISH Protocol for Identifying Enterococcal Bloodstream Pathogens
  
• PPD to Spin Out Compound-Partnering Segment, Acquire Chinese CRO, and Invest $100M in Celtic Therapeutics
  
• Biosearch Grants Micronics Rights to Its Nucleic Acid Assay Chemistries
  
• Simcere Fortifies Stake in Chinese H1N1 Vaccine Firm to Over 50%
  
• Novartis to Invest $1.25B in Two New Facilities in China